JOSÉ LUIS
REVUELTA HERRERO
Profesor asociado de Ciencias de la Salud
Eva
González-Haba Peña
Publicaciones en las que colabora con Eva González-Haba Peña (7)
2023
-
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 7, pp. 2855-2882
-
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
Frontiers in Oncology, Vol. 13
2022
-
A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application
Frontiers in Oncology, Vol. 12
-
A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital
Frontiers in Public Health, Vol. 10
-
Medication guide for the perioperative management of oral antineoplastic agents in cancer patients
Expert Opinion on Drug Safety, Vol. 21, Núm. 1, pp. 107-119
2021
-
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice
Supportive Care in Cancer, Vol. 29, Núm. 8, pp. 4673-4681
2020
-
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety
Health Informatics Journal, Vol. 26, Núm. 3, pp. 1995-2010